H. Lundbeck A/S header image

H. Lundbeck A/S

HLUN A

Equity

ISIN DK0061804697 / Valor 119252584

Nasdaq Copenhagen Equities (2026-01-30)

DKK 36.85+1.38%

H. Lundbeck A/S
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

H. Lundbeck A/S is a global pharmaceutical company headquartered in Denmark, with a presence in over 50 countries. The company specializes in developing and distributing innovative treatments for brain diseases, leveraging its production facilities in Denmark, France, and Italy, and research centers in Denmark and the United States. Since its listing on Nasdaq Copenhagen in 1999, Lundbeck has been primarily owned by the Lundbeck Foundation, which holds approximately 70% of its shares and supports medical research and educational initiatives. With a history spanning over 70 years, Lundbeck has been instrumental in providing therapies that address neurological and psychiatric disorders, impacting millions of patients worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

4.39%1Y

56.7%3Y

-15.9%5Y

Performance

49.6%1Y

35.6%3Y

34.5%5Y

Volatility

1162 M

Market cap (USD)

50,961

Daily traded volume (Shares)

34 / 33.375

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Inspire Medical Systems Inc

Inspire Medical Systems Inc Valor: 41329373

Annual Return

-50%0%+50%

Risk level

110

-3.51%USD 75.78

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

0.79%GBP 15.29

Spire Healthcare Group PLC

Spire Healthcare Group PLC Valor: 24881418

Annual Return

-50%0%+50%

Risk level

110

-0.49%GBP 2.04

Royalty Pharma PLC

Royalty Pharma PLC Valor: 55041695

Annual Return

-50%0%+50%

Risk level

110

2.01%USD 41.68

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

0.34%USD 23.47

Beiersdorf AG

Beiersdorf AG Valor: 324660

Annual Return

-50%0%+50%

Risk level

110

1.44%EUR 100.45

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

1.06%DKK 42.12

Dermapharm Holding SE

Dermapharm Holding SE Valor: 40166352

Annual Return

-50%0%+50%

Risk level

110

-1.27%EUR 34.85

Edwards Lifesciences Corp

Edwards Lifesciences Corp Valor: 1065343

Annual Return

-50%0%+50%

Risk level

110

-0.16%USD 81.36

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

-0.36%CHF 96.60

SIX

FactSet

Clearbit

Logos provided by Clearbit